Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Adjuvant Capecitabine vs Observation in Curatively Resected Stage IB Gastric Cancer
KCT0001298Phase 3Recruiting
- Sponsor
- Asan Medical Center
- Start
- Nov 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in gastric cancer (GC) comparing Adjuvant capecitabine with Observation alone (2 arms). Started Nov 2013; status: recruiting.
02
Drugs
capecitabine
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on KCT0001298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001298.